Ozempic Dosing Schedule (2026 Guide)
Week-by-week titration from 0.25 mg starter to the 2.0 mg maximum, with HbA1c and weight outcomes from the SUSTAIN program. Verified against the current Novo Nordisk label.
Ozempic starts at 0.25 mg once weekly for the first 4 weeks (a starter dose, not a treatment dose). The dose is then increased to 0.5 mg, with optional escalations to 1.0 mg or the maximum 2.0 mg every 4 weeks if needed for glycemic control. The standard maintenance doses for type 2 diabetes are 0.5 mg, 1.0 mg, and 2.0 mg once weekly. Most patients land at 0.5 mg or 1.0 mg for HbA1c control. Reaching the 2.0 mg maximum takes about 4 months from start.
Ozempic titration schedule
Four strengths total. Three of them (0.5 mg, 1.0 mg, 2.0 mg) are FDA-approved as maintenance doses for type 2 diabetes. The 0.25 mg dose is a starter, not a treatment dose.
| When | Dose | Purpose | What to expect |
|---|---|---|---|
| Weeks 1-4 | 0.25 mg | Starter dose | Body adjusts to semaglutide. Mild nausea is most common in the first 1 to 2 weeks. This dose does not produce meaningful HbA1c reduction on its own. |
| Weeks 5+ | 0.5 mg | First maintenance optionMaintenance | Meaningful HbA1c reduction begins. Many type 2 diabetes patients land here as their long-term dose. Side effects often peak briefly after the dose increase, then settle. |
| After 4+ weeks at 0.5 mg, optional | 1.0 mg | Second maintenance optionMaintenance | Used when 0.5 mg is not getting HbA1c to goal. Stronger glycemic effect with somewhat higher GI side effect rates. |
| After 4+ weeks at 1.0 mg, optional | 2.0 mg | Maximum maintenance doseMaintenance | FDA-approved ceiling. SUSTAIN-FORTE showed about 2.2% HbA1c reduction at 40 weeks (vs ~1.9% at 1.0 mg). Side effect rates are higher than at 0.5 mg. |
Most patients land at 0.5 mg or 1.0 mg long-term. The 2.0 mg maximum (FDA-approved in 2022) is reserved for patients whose HbA1c is not at goal on 1.0 mg. Patients seeking semaglutide for weight loss should consider Wegovy, which has higher approved doses (2.4 mg standard, 7.2 mg HD).
HbA1c and weight outcomes by maintenance dose
Aggregated from the SUSTAIN-FORTE and SUSTAIN clinical trial program in adults with type 2 diabetes:
SUSTAIN program, ~40 weeks, adults with type 2 diabetes
SUSTAIN program, ~40 weeks, adults with type 2 diabetes
SUSTAIN-FORTE, 40 weeks, adults with type 2 diabetes
Weight loss from Ozempic at T2D doses runs lower than from Wegovy at weight-loss doses (2.4 mg or 7.2 mg). The molecule is identical; the dose strength and duration drive the outcome difference.
How to inject Ozempic
- Abdomen (at least 2 inches from the navel)
- Front of thigh
- Back of upper arm
Rotate the injection site each week.
Once weekly, any day of the week
Take with or without food, with or without other medications. Time of day does not matter clinically.
If you miss a dose
Take the missed dose as soon as you remember.
Skip the missed dose. Take your next dose on your regularly scheduled day.
If your next scheduled dose is within 2 days, skip the missed dose. Do not double up.
Ozempic has a slightly longer missed-dose window than Wegovy (5 days vs 4 days) because it covers lower dose strengths. Never take two doses to make up for a missed one.
When prescribers adjust the schedule
If side effects at a new dose are pronounced, your prescriber may keep you on the previous dose for additional weeks before stepping up.
If 0.5 mg or 1.0 mg gets your HbA1c to goal, there is no clinical requirement to escalate further. Many type 2 diabetes patients stay at 0.5 mg or 1.0 mg long-term.
If side effects at a higher dose become unmanageable, your prescriber may step you back down. Lower doses still provide meaningful glycemic benefit.
Common side effects, with frequency
From the prescribing information at maintenance doses (0.5 mg and above). Side effects tend to peak briefly after each dose increase, then settle.
| Side effect | Frequency | Practical notes |
|---|---|---|
| Nausea | Up to 20% | Most common in the first 4 weeks of each dose increase. Smaller meals and avoiding fatty or spicy foods helps. |
| Diarrhea | Up to 9% | Often occurs in the first weeks. Hydration is important. |
| Vomiting | Up to 9% | More common at higher doses. Worth raising with your clinician if persistent. |
| Constipation | Up to 5% | Adequate fiber and fluid intake helps. |
| Abdominal pain | Up to 7% | Persistent or severe abdominal pain warrants immediate clinical attention. |
| Decreased appetite | Common | Often a desired side effect alongside glycemic control. |
| Hypoglycemia | Higher when combined with insulin or sulfonylureas | Ozempic alone rarely causes hypoglycemia. Risk rises when stacked with insulin or sulfonylureas; your prescriber may lower those doses. |
Storage
- Refrigeration: Refrigerate at 36 to 46 degrees Fahrenheit (2 to 8 degrees Celsius) in the original carton, protected from light.
- After first use: After first use, the pen can be stored at room temperature up to 86 degrees Fahrenheit (30 degrees Celsius) or refrigerated for up to 56 days.
- Do not freeze: Do not freeze. Discard if frozen.
- Handling: Do not shake the pen vigorously.
Frequently asked questions
Need a clinician who actually walks you through the schedule?
Take our 90-second quiz to get matched with an Ozempic provider whose dosing approach fits how you want to be cared for.
Dosing schedule, available strengths, missed-dose guidance, storage, and administration come directly from the Ozempic (semaglutide) Prescribing Information from Novo Nordisk. Trial outcomes are aggregated from the SUSTAIN clinical trial program (SUSTAIN-1 through SUSTAIN-FORTE). Side effect frequencies reflect rates reported in the prescribing information at the indicated maintenance doses.